Breast cancer diagnostics company Volpara Health Technologies has announced new US healthcare provider contracts with a combined total value of $12.3 million.
In a statement to the ASX, Wellington-based Volpara said it had signed new five-year contracts with five providers – Bon Secours Mercy
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
